| MolName | (4Z)-4-[[4-[4-[(2Z)-2-(3-carboxy-5-oxo-1-phenylpyrazol-4-ylidene)hydrazinyl]-2-sulfophenyl]-3-sulfophenyl]hydrazinylidene]-5-oxo-1-phenylpyrazole-3-carboxylic acid |
| MolecularFormula | C32H22N8O12S2 |
| Smiles | OC(C(/C(/C1=O)=N/Nc(cc2)cc(S(O)(=O)=O)c2-c(ccc(N/N=C(/C(C(O)=O)=NN2c3ccccc3)\C2=O)c2)c2S(O)(=O)=O)=NN1c1ccccc1)=O |
| InChI | InChI=1S/C32H22N8O12S2/c41-29-25(27(31(43)44)37-39(29)19-7-3-1-4-8-19)35-33-17-11-13-21(23(15-17)53(47,48)49)22-14-12-18(16-24(22)54(50,51)52)34-36-26-28(32(45)46)38-40(30(26)42)20-9-5-2-6-10-20/h1-16,33-34H,(H,43,44)(H,45,46)(H,47,48,49)(H,50,51,52) |
| InChIK | WVYUWCXLUCGZGP-UHFFFAOYSA-N |
| TotalMolweight | 774.703 |
| Molweight | 774.703 |
| MonoisotopicMass | 774.079862 |
| CLogP | 1.7008 |
| CLogS | -2.44 |
| H Acceptors | 20 |
| H Donors | 6 |
| TotalSurfaceArea | 514.5 |
| Relative PSA | 0.46216 |
| PolarSurfaceArea | 314.22 |
| Druglikeness | 3.1148 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | high |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.48148 |
| Fragments | 1 |
| Non HAtoms | 54 |
| NonCHAtoms | 22 |
| Electronegative Atoms | 22 |
| Rotatable Bond | 11 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 6 |
| Symmetricatoms | 30 |
| AcidicOxygens | 4 |
| StereoCon |
Click to Load Molecule:
1 - (4Z)-4-[[4-[4-[(2Z)-2-(3-carboxy-5-oxo-1-phenylpyrazol-4-ylidene)hydrazinyl]-2-sulfophenyl]-3-sulfophenyl]hydrazinylidene]-5-oxo-1-phenylpyrazole-3-carboxylic acid | 2 - (4Z)-4-[[4-[4-[(2Z)-2-(3-carboxy-5-oxo-1-phenylpyrazol-4-ylidene)hydrazinyl]-2-sulfophenyl]-3-sulfophenyl]hydrazinylidene]-5-oxo-1-phenylpyrazole-3-carboxylic acid